| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals, Inc. | VP of Finance & Administration | Common Stock | 20,600 | $129,279 | $6.28 | 09 Dec 2022 | Direct |
| Reneo Pharmaceuticals, Inc. | VP of Finance & Administration | Stock option (right to buy) | 90,000 | 09 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OKUR | Reneo Pharmaceuticals, Inc. | 09 Dec 2022 | 1 | $0 | 4 | VP of Finance & Administration | 13 Dec 2022, 17:13 |
| OKUR | Reneo Pharmaceuticals, Inc. | 31 Mar 2022 | 0 | $0 | 3 | VP of Finance & Administration | 05 Apr 2022, 20:02 |